Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Steris (STE)

STERIS revenue rises 7% to $1.3 billion; adjusted EPS $2.14 vs $1.86 a year earlier

Positive Impact 3 of 5 earnings Written later

STERIS reported fiscal 2025 second-quarter results for the period ended September 30, 2024, with revenue from continuing operations up 7% to $1.3 billion and diluted EPS from continuing operations of $1.51, up from $1.20. The company reiterated its fiscal 2025 outlook, including adjusted EPS of $9.05 to $9.25, so shareholders see higher quarterly profit with no change to guidance.

Key points

  • Revenue rose 7% to $1.3 billion from $1.2 billion a year earlier.
  • Net income was $150.2 million, or $1.51 per diluted share, versus $119.8 million, or $1.20 per diluted share.
  • Adjusted EPS was $2.14, up from $1.86 in the prior-year quarter.
  • Fiscal 2025 adjusted EPS outlook of $9.05 to $9.25 was reiterated, and free cash flow for the first half was $344.5 million.

The filing

CompanySteris (STE)
Form8-K, current report
Filed with the SECNov 6, 2024, 4:45 PM ET
Accession number0001757898-24-000017

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 06, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.